Proteasome inhibitor-induced model of Parkinson's disease

Abstract excerpt

We recently reported that systemic administration of a proteasome inhibitor induced a progressive levodopa-responsive, bradykinetic syndrome in rats with imaging, pathological, and biochemical features that strikingly resemble what is found in PD. This model has the potential to be a useful tool for studying the mechanism of cell death in Parkinson's disease and for testing putative neuroprotective agents. Since...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Nuclear Receptors and Signaling
• Share to Parkinson's Disease Mechanisms and Treatments
• Share to Ubiquitin and proteasome pathways